Regulatory guidance for pharmaceutical companies to prepare for UK’s withdrawal from EU
EMA and European Commission publish updated Q&As
The European Medicines Agency (EMA) and the European Commission have published additional guidance to help pharmaceutical companies prepare for the United Kingdom’s withdrawal from the European Union (EU).
Companies are reminded to plan in advance for the situation that the United Kingdom (UK) will leave the EU on 29 March 2019 in order to avoid any impact on the continuous supply of medicines for human and veterinary use within the EU.
This version is an update of the initial questions-and-answers document that was published at the end of May 2017. Updates are marked ‘NEW’ and include additional information on how the UK’s withdrawal from the EU will affect marketing applications and authorisations for different types of medicinal products, for example, generic, hybrid and biosimilar medicines.
The guidance relates to both human and veterinary medicines, unless otherwise indicated.
Earlier this week, the Agency published the first version of its procedural guidance for industry which outlines the practical and simplified requirements that companies should follow to make sure that necessary changes to their marketing authorisation are made by the end of March 2019, to allow for the continued marketing of their medicine in the European Economic Area (EEA) after Brexit.
Companies are advised to regularly check EMA’s dedicated webpage on the consequences of the UK’s withdrawal from the EU.
This questions-and-answers document follows the publication of the European Commission/EMA notice to marketing authorisation holders of centrally authorised medicines for human and veterinary use on 2 May 2017.
Questions and answers related to the United Kingdom's withdrawal from the European Union with regard to the medicinal products for human and veterinary use within the framework of the centralised procedure (01/12/2017)
Latest News from
Four Western Balkans’ fact-checking organisations join Facebook’s platform against disinformation14/08/2020 15:25:00
Disinformation and misinformation proliferated around the world including in the Western Balkans as the COVID-19 pandemic started. Western Balkans’ fact-checking organisations intensified their work on exposing and countering disinformation, raising the awareness and contributing to local public debates about the problem. As of 30 July, leading fact-checking organisations from Bosnia and Herzegovina, Montenegro, North Macedonia and Serbia continue their valuable work also within the third-party fact-checking program, which is a part of the Facebook’s strategy against disinformation.
Coronavirus: Commission concludes further talks to secure future vaccine14/08/2020 13:25:00
The European Commission yesterday concluded exploratory talks with Johnson & Johnson to purchase a potential vaccine against COVID-19. This
State aid: Commission approves €2 billion Italian guarantee scheme to support trade credit insurance market in the context of the coronavirus outbreak14/08/2020 09:25:00
The European Commission has approved, under EU State aid rules, a €2 billion Italian scheme to support the trade credit insurance market in the context of the coronavirus outbreak.
Declaration by the High Representative on behalf of the EU on the alignment of certain countries concerning restrictive measures in view of the situation in Venezuela13/08/2020 13:25:00
On 29 June 2020, the Council adopted Decision (CFSP) 2020/898.
Cambodia loses duty-free access to the EU market over human rights concerns13/08/2020 10:25:00
As of yesterday, 12 August, some of Cambodia's typical export products such as garments, footwear and travel goods are subject to the European Union's customs duties.
State aid: Commission approves €30 million Estonian measure to support Nordica in the context of the coronavirus outbreak13/08/2020 09:25:00
The European Commission has approved a €30 million Estonian measure to provide a share capital increase and a subsidised interest loan to the state-owned aviation company “Nordica Aviation Group AS” (“Nordica”).
Belarus: Declaration by the High Representative on behalf of the European Union on the presidential elections12/08/2020 15:25:00
On 9 August, Presidential elections took place in the Republic of Belarus.
Coronavirus: 23 new research projects to receive €128 million in EU funding12/08/2020 13:25:00
The Commission will support 23 new research projects with €128 million in response to the continuing coronavirus pandemic.
State aid: Commission approves German aid scheme to support airports affected by the coronavirus outbreak12/08/2020 12:33:00
The European Commission has approved a German aid scheme to support airports in the context of the coronavirus outbreak.
State aid: Commission opens in-depth investigation into public support for expansion of LG Chem's electric vehicles battery plant in Poland12/08/2020 10:25:00
The European Commission has opened an in-depth investigation to assess whether €95 million of public support granted by Poland to chemical company LG Chem Group (“LG Chem”) for investing in the expansion of its battery cell production facility for electric vehicles (EV) in Biskupice Podgórne in the Dolnoślaskie region (Poland) is in line with EU rules on regional State aid.